Newsroom All the latest news from the Pierre Fabre Group Page inner navigation PRESS RELEASES PRESS AREA NEWS PUBLICATIONS TWITTER Press releases Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Écrit le Min Max Appliquer Press release Fernando Junoy appointed Pierre Fabre Laboratories’ International Managing Director 31 October 2024 Press release Dosing of the first patient in the phase I/II trial evaluating PFL-002/VERT-002, a targeted therapy in oncology 24 October 2024 Press release Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology. 7 October 2024 Load more Presse area Are you a journalist? Find all the press releases of the Pierre Fabre group. Join us News Filter Year Year20242023202220212020 Month MonthJanuaryFebruaryMarchAprilMayJuneJulyAugustSeptemberOctoberNovemberDecember Tags (field_news_tags) - Any -#CRCawarenessDuoDayE-SANTÉLittle Big DreamsInternational Men's Day#OurBreastJourneyCOLLECTION PIERRE FABREConsortiumSustainable developmentDIGITALEADVESMOThe Gustave Roussy PrizeLettre OuverteLymphomaMedicalInnovationMedicalScienceLiaisonMelanomaMSLPink OctoberOncologyANNUAL REPORTStudyEventsPierre Fabre FoundationInnovationNominationsPartnershipsAwardsStrategyTalents Écrit le Min Max Appliquer MSL Mattia Pagnani: A Medical Science Liaison (MSL) Aiming to Enhance Patient Outcomes in Italy 2 December 2024 The Gustave Roussy Prize Launch of the Gustave Roussy Prize 20 November 2024 International Men's Day Events Men's Health Month 29 October 2024 MSL A Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany. 29 October 2024 Load more Publications 18 July 2024 Pierre Fabre Laboratories 2024 Annual Report : New ways to care 25 August 2023 2023 Annual report of Pierre Fabre group Load more Follow our live news Social media type (field_social_media_type) FacebookInstagramTwitterLinkedin Appliquer Pierre Fabre Group @pierrefabregroup [Inno 360°] To innovate, you need to overcome major challenges. 109 days ago Pierre Fabre Group @pierrefabregroup [Inno 360°] To innovate, you need to overcome major challenges. 111 days ago Pierre Fabre Group @pierrefabregroup Unlocking Advanced Skin Protection ☀️ 117 days ago Pierre Fabre Group @pierrefabregroup [Made in France] We shared a few words with Celia Perron, from the #SporTeamPierreFabre, to learn what team 124 days ago Pierre Fabre Group @pierrefabregroup [Step by Step] 🌿 Connaissez-vous la menthe aquatique ? 143 days ago Pierre Fabre Group @pierrefabregroup 🇫🇷 Félicitations à nos incroyables athlètes de la Spor'Team Pierre Fabre, Benjamin Robert (800m), Clémence 144 days ago Pierre Fabre Group @pierrefabregroup 🌟 [Inno360] Experience remarkable results with the innovative power of Ducray’s Melascreen with Camille Béz 153 days ago Pierre Fabre Group @pierrefabregroup 🌞🚙 Le #SummerTourAvène arrive près de chez vous ! 🚙🌞 156 days ago
Press release Fernando Junoy appointed Pierre Fabre Laboratories’ International Managing Director 31 October 2024
Press release Dosing of the first patient in the phase I/II trial evaluating PFL-002/VERT-002, a targeted therapy in oncology 24 October 2024
Press release Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology. 7 October 2024
MSL Mattia Pagnani: A Medical Science Liaison (MSL) Aiming to Enhance Patient Outcomes in Italy 2 December 2024
MSL A Medical Science Liaison (MSL) Leading the Evolution of Healthcare Practices in Germany. 29 October 2024
